AFCG · Advanced Flower Capital Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 13, 2026TL;DR. AFC reported Q2 2026 net investment income of $0.15 per share with NAV per share rising to $8.25 from $7.90, while total investment income declined sequentially to $8.7 million from $9.8 million due to non-recurring exit fees in the prior quarter, and legacy cannabis loan workouts continued with a binding $12.5 million Debbie asset sale.
- + NAV per share increased to $8.25 from $7.90, driven by NII, share buyback accretion, and unrealized appreciation
- + Share repurchases at a discount to NAV generated $0.17 per share of accretion, with $2.2 million remaining under the program
- + Investment portfolio grew to $289.8 million across 17 companies with a 13.2% weighted average yield
- + Liquidity remains robust with over $70 million available post-quarter-end debt paydowns
- + Legacy cannabis workouts advanced with binding $12.5 million Debbie asset sale and DMA dispensary closings
- − Total investment income declined sequentially to $8.7 million from $9.8 million as Q1 exit fees did not recur
- − Justice Grown loan is in maturity default with active Article 9 foreclosure proceedings
- − Net debt-to-equity rose to 0.53x from 0.48x, with management citing ~1.0x as a target leaving room to lever but indicating below-target current position
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Asset coverage | 190% | Q2 FY2026 | — |
| Debt-to-equity | 1.1 | Q2 FY2026 | — |
| Gross investment fundings | $17.2M | Q2 FY2026 | — |
| Investment portfolio at fair value | $289.8M | Q2 FY2026 | — |
| Net debt-to-equity | 0.53 | Q2 FY2026 | — |
| Net investment fundings | $8M | Q2 FY2026 | — |
| Number of portfolio companies | 17 | Q2 FY2026 | — |
| Share repurchase program authorization | $5M | Q2 FY2026 | — |
| Shares repurchased | 839,406 | Q2 FY2026 | — |
| Total available liquidity | $70M | Q2 FY2026 | — |
| Weighted average interest rate on debt outstanding | 6.3% | Q2 FY2026 | — |
| Weighted average share repurchase price | $3.29 | Q2 FY2026 | — |
| Weighted average yield on income producing debt investments | 13.2% | Q2 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AFCG
this stock
Advanced Flower Capital Inc.
|
$80.49M | +26.3% | -46.2% | 18.7 | 3.2% |
|
BLK
BlackRock, Inc.
|
$347.03B | -1.1% | +16.2% | 25.6 | 0.6% |
|
KKR
KKR & Co. Inc.
|
$86.77B | -28.4% | -11.0% | — | 1.5% |
|
BX
Blackstone Inc.
|
$85.57B | -27.3% | +9.2% | 25.6 | 2.6% |
|
BN
BROOKFIELD Corp /ON/
|
$81.46B | -20.5% | — | — | 0.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AFCG | +2.9% | +3.2% | +36.4% | +0.0% | +26.3% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +3.5% | +3.0% | +24.2% | +0.6% | +14.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.